Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to BDTX Full portfolio

Position in BDTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$73,176
+$72,346 QoQ
Shares Held
39,555
+11707.5% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 96 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. BDTX ranks #292 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in BDTX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $73,176 39,555
2025-06-30 $830 335
2025-03-31 $31,886 20,572
2024-12-31 $43,054 20,119
2024-09-30 $61,713 14,187
2024-06-30 $63,925 13,718
2024-03-31 $1,414 279
2023-12-31 $769 274
2023-09-30 $1,033 360
2023-06-30 $1,247 247
2023-03-31 $1,211 641
2022-12-31 $430 239
2022-09-30 $1,242 735
2022-06-30 $1,847 751
2022-03-31 $5,346 1,930
2021-12-31 $53,326 10,005
2021-09-30 $115,630 13,668
2021-06-30 $163,089 13,379
2021-03-31 $16,250,655 669,854
2020-12-31 $21,269,433 663,633
2020-09-30 $13,977,956 462,387
2020-06-30 $11,995,867 284,532
2020-03-31 $453,990 18,196